Netflix announced it’s acquiring Ready Player Me, the avatar creation platform, which the streaming giant hopes to leverage ...
Eisai has filed for approval in Japan for tasurgratinib, its small-molecule fibroblast growth factor (FGF) receptor inhibitor, as a treatment for biliary tract cancers with FGFR2 gene fusion mutations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback